MENU

SABS SAB Biotherapeutics Forecast, Technical & Fundamental Analysis

SAB Biotherapeutics Inc is a clinical-stage biopharmaceutical company focused on developing multi-specific, high-potency, human immunoglobulin G (hIgG) to treat and prevent immune and autoimmune disorders... Show more

SABS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
SABS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

SABS is expected to report earnings to fall 2.75% to -27 cents per share on November 17

SAB Biotherapeutics SABS Stock Earnings Reports
Q3'26
Est.
$-0.27
Q2'26
Missed
by $0.01
Q1'26
Beat
by $0.23
Q4'25
Missed
by $0.13
Q3'25
Missed
by $0.09
The last earnings report on August 06 showed earnings per share of -28 cents, missing the estimate of -26 cents. With 599.61K shares outstanding, the current market capitalization sits at 309.35M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
777 West 41st Street
Phone
+1 305 845-2813
Employees
86
Web
https://www.sab.bio
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TRSPX81.64N/A
N/A
Nuveen S&P 500 Index Retire
RLECX24.56N/A
N/A
Russell Inv US Small Cap Equity C
SAUMX36.75N/A
N/A
SA US Small Company
VELIX17.24N/A
N/A
VELA Large Cap Plus I
RDWBX16.43-0.15
-0.90%
American Funds Dvlpg Wld Gr&Inc R-2

SABS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SABS has been loosely correlated with REVB. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if SABS jumps, then REVB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SABS
1D Price
Change %
SABS100%
-1.72%
REVB - SABS
48%
Loosely correlated
-1.10%
INKT - SABS
47%
Loosely correlated
+2.28%
CYPH - SABS
46%
Loosely correlated
-10.20%
TECX - SABS
35%
Loosely correlated
-6.14%
BEAM - SABS
31%
Poorly correlated
-3.20%
More
SAB Biotherapeutics (SABS) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com